Masimo (NASDAQ:MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1 advanced health tracking watch for use in its telehealth and telemedicine programs. Masimo W1, which offers accurate, continuous measurements of key physiological parameters, is available in the UK as a medical device that integrates with the Masimo SafetyNet remote patient management platform.
Stephens & Co. Maintains Overweight on FedEx, Raises Price Target to $295
Stephens & Co. analyst Jack Atkins maintains FedEx (NYSE:FDX) with a Overweight and raises the price target from $200 to $295.
